Company profile: QT Imaging
1.1 - Company Overview
Company description
- Provider of breast imaging services via tomographic transmission ultrasound, offering non-invasive 3D imaging without contrast agents or radiation. Products include the Breast Acoustic CT System, QTscan, and an AI-enabled diagnostic platform leveraging transmission and reflection modalities, plus QT Imaging 3D technology for tissue-specific microanatomy and 3D Acoustic CT for potential whole-body diagnostics.
Products and services
- AI-Enabled Diagnostic Platform: A custom-engineered artificial intelligence algorithm utilizing transmission and reflection acoustic energy modalities to aid in the diagnosis of cancer based on breast imaging data
- Breast Acoustic CT™ System: A non-invasive, clinical-grade breast imaging system using transmission and reflection ultrasound to generate 3D images without contrast agents or ionizing radiation through tomographic acquisition
- QTscan®: A diagnostic-grade imaging apparatus that generates breast images via both reflection and transmission modalities to assist clinicians in identifying different breast tissues in three-dimensional views
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to QT Imaging
Immune-Onc Therapeutics
HQ: United States
Website
- Description: Provider of therapeutic antibodies for cancer treatment, developing IO-202, a humanized IgG1 targeting LILRB4 to deplete LILRB4-expressing cells in blood cancers, autoimmune, and inflammatory diseases; IO-108, a fully human IgG4 targeting LILRB2 to block cancer-associated immune suppression in solid tumors; and IO-312, a bispecific targeting LILRB4 and CD3 for AML and other hematologic malignancies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immune-Onc Therapeutics company profile →
Arvinas
HQ: United States
Website
- Description: Provider of PROTAC protein degrader therapies that harness the body's natural protein disposal system to degrade disease-causing proteins for life-threatening diseases, from discovery to commercialization. Pipeline includes vepdegestrant (ER+ breast cancer), ARV-766 (licensed to Novartis; prostate cancer), ARV-393 (BCL6), ARV-102 (LRRK2), and alpha-synuclein degraders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arvinas company profile →
Antigen Express
HQ: United States
Website
- Description: Provider of proprietary vaccine formulation platform and products addressing large unmet medical needs by focusing on stimulation of critical T helper cells. The technology enables antigen-specific stimulation or suppression of T-helper responses to virtually any antigen.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Antigen Express company profile →
Broncus Medical
HQ: United States
Website
- Description: Provider of minimally invasive medical devices for emphysema and other lung diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Broncus Medical company profile →
HistoSonics
HQ: United States
Website
- Description: Provider of non-invasive medical devices and technologies for interventional radiology and surgical robotics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HistoSonics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for QT Imaging
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to QT Imaging
2.2 - Growth funds investing in similar companies to QT Imaging
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for QT Imaging
4.2 - Public trading comparable groups for QT Imaging
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →